Patents by Inventor Antonio GERMANI

Antonio GERMANI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INDOMETHACIN PHARMACEUTICAL COMPOSITION
    Publication number: 20240024285
    Abstract: A pharmaceutical composition contains Indomethacin. In particular, the composition is a suppository containing a hard fat as a base material.
    Type: Application
    Filed: July 12, 2023
    Publication date: January 25, 2024
    Applicant: FULTON MEDICINALI S.P.A.
    Inventors: Alessandro GALLI, Simone SARNO, Claudio BELLONI, Antonio GERMANI
  • INDOMETHACIN PHARMACEUTICAL COMPOSITION
    Publication number: 20240024284
    Abstract: A pharmaceutical composition contains Indomethacin. The composition is a suppository containing a hard fat as a base material.
    Type: Application
    Filed: July 20, 2022
    Publication date: January 25, 2024
    Inventors: Alessandro GALLI, Simone SARNO, Claudio BELLONI, Antonio GERMANI
  • Crystal forms of immunomodulatory drug pomalidomide and co-crystal with gentisic acid
    Patent number: 10155740
    Abstract: The present invention relates to novel solid crystal forms of Pomalidomide named Form B, Form M, Pomalidomide:Gentisic acid co-crystal and their preparation. Advantageously, these solid forms are used in pharmaceutical compositions for the treatment and the prevention of multiple myeloma, of inflammatory diseases, of autoimmune diseases, of immune diseases, of myelodysplastic syndrome, of myeloproliferative disorders, of anemia, of scleroderma, amyloidosis or of other diseases associated with unwanted angiogenesis.
    Type: Grant
    Filed: November 24, 2016
    Date of Patent: December 18, 2018
    Assignee: F.I.S.—FABBRICA ITALIANA SINTETICI S.P.A
    Inventors: Alessandro Gagnoni, Antonio Germani, Nicolas Tesson
  • CRYSTAL FORMS OF IMMUNOMODULATORY DRUG POMALIDOMIDE AND CO-CRYSTAL WITH GENTISIC ACID
    Publication number: 20180099944
    Abstract: The present invention relates to novel solid crystal forms of Pomalidomide named Form B, Form M, Pomalidomide:Gentisic acid co-crystal and their preparation. Advantageously, these solid forms are used in pharmaceutical compositions for the treatment and the prevention of multiple myeloma, of inflammatory diseases, of autoimmune diseases, of immune diseases, of myelodysplastic syndrome, of myeloproliferative disorders, of anemia, of scleroderma, amyloidosis or of other diseases associated with unwanted angiogenesis.
    Type: Application
    Filed: November 24, 2016
    Publication date: April 12, 2018
    Inventors: Alessandro GAGNONI, Antonio GERMANI, Nicolas TESSON